Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | CA12 | O43570 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 5/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | GALR3 | O60755 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20505340 | 0.83 | CES2 (0.55) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL30352763 | 0.82 | CYP2C9 (0.72) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL129669 | 0.82 | CYP2C9 (0.72) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL618056 | 0.81 | KDM4E (0.65) | KDM4EGLAHPGDCYP2C9CES2 | |
| SCHEMBL9487167 | 0.80 | CYP2C9 (0.69) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL28768383 | 0.80 | MAOA (0.58) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL9864432 | 0.80 | ALOX15 (0.52) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL13740129 | 0.80 | DGAT1 (0.62) | ALDH1A1TSHRKDM4EMAPTGAA | |
| SCHEMBL55915 | 0.80 | MAOA (0.58) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL29433676 | 0.80 | MAOA (0.58) | ALDH1A1KDM4EMAPTCYP3A4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 660 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | claimed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | claimed |
| CN-118973990-A | Process for producing cyclic diketone compound | 花王株式会社 | 2024-11-15 | — | — | CN | claimed |
| WO-2023189722-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | 花王株式会社 | 2023-10-05 | — | — | WO | claimed |
| CN-113087683-B | Nitrogen-substituted benzothiazolinone XOR/URAT1 dual inhibitor and preparation method and application thereof | 华南理工大学 | 2022-04-22 | — | — | CN | claimed |
| CN-110028443-B | Preparation method of tricyclic compound drug intermediate for regulating FXR activity | 济南周行医药科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-113816940-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-21 | — | — | CN | claimed |
| CN-113754634-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113087683-A | Nitrogen-substituted benzothiazolinone XOR/URAT1 dual inhibitor and preparation method and application thereof | 华南理工大学 | 2021-07-09 | — | — | CN | claimed |
| CN-110028443-A | A kind of preparation method adjusting the active tricyclic compound class pharmaceutical intermediate of FXR | 济南周行医药科技有限公司 | 2019-07-19 | — | — | CN | claimed |
| CN-105418404-A | Synthesis method of 2-hydroxyl-4-bromobenzoic acid | DING YUQIN | 2016-03-23 | — | — | CN | claimed |
| EP-0218689-B1 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1990-08-01 | — | — | EP | claimed |
| EP-0263209-A2 | Anthelmintic quinolinyl acylhydrazones | THE UPJOHN COMPANY (US) | 1988-04-13 | — | — | EP | claimed |
| WO-1986005982-A3 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1987-04-23 | — | — | WO | claimed |
| EP-0218689-A1 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES AND COMPOSITIONS. | UPJOHN CO (US) | 1987-04-22 | — | — | EP | claimed |
| WO-1986005982-A2 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | UPJOHN CO (US) | 1986-10-23 | — | — | WO | claimed |
| US-20260125367-A1 | CANCER TREATMENTS TARGETING CANCER STEM CELLS | REMEDY PLAN, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| WO-1986005982-A2 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | UPJOHN CO (US) | 1986-10-23 | — | — | WO | disclosed |
| US-4006243-A | FUNGICIDE, BACTERICIDE, YEAST | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | ALDH1A1 699/4885CA12 2616/4885CA1 2942/4885 |
| US-20260125367-A1 | CANCER TREATMENTS TARGETING CANCER STEM CELLS | MCL1, MALT1, BCL6 | ALDH1A1 56/4885CA12 74/4885CA1 31/4885 |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | ACTN1, ARPC3, ARPC4 | ALDH1A1 1502/4885CA12 3688/4885CA1 4197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.